These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3629 related items for PubMed ID: 31054549

  • 41. Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).
    van den Berg K, Schaap DP, Voogt ELK, Buffart TE, Verheul HMW, de Groot JWB, Verhoef C, Melenhorst J, Roodhart JML, de Wilt JHW, van Westreenen HL, Aalbers AGJ, van 't Veer M, Marijnen CAM, Vincent J, Simkens LHJ, Peters NAJB, Berbée M, Werter IM, Snaebjornsson P, Peulen HMU, van Lijnschoten IG, Roef MJ, Nieuwenhuijzen GAP, Bloemen JG, Willems JMWE, Creemers GJM, Nederend J, Rutten HJT, Burger JWA.
    BMC Cancer; 2022 Sep 06; 22(1):957. PubMed ID: 36068495
    [Abstract] [Full Text] [Related]

  • 42. [An initial exploration of the application of transanal endoscopic microsurgery in rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy].
    Xue XQ, Zhou JL, Lin GL, Bai XS, Xiao Y, Wu B, Qiu HZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun 25; 22(6):560-565. PubMed ID: 31238635
    [Abstract] [Full Text] [Related]

  • 43. Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
    Dellas K, Höhler T, Reese T, Würschmidt F, Engel E, Rödel C, Wagner W, Richter M, Arnold D, Dunst J.
    Radiat Oncol; 2013 Apr 15; 8():90. PubMed ID: 23587311
    [Abstract] [Full Text] [Related]

  • 44. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C, Pericay C, Aparicio J, Salud A, Safont M, Massuti B, Vera R, Escudero P, Maurel J, Marcuello E, Mengual JL, Saigi E, Estevan R, Mira M, Polo S, Hernandez A, Gallen M, Arias F, Serra J, Alonso V.
    J Clin Oncol; 2010 Feb 10; 28(5):859-65. PubMed ID: 20065174
    [Abstract] [Full Text] [Related]

  • 45. Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial.
    Lin ZY, Zhang P, Chi P, Xiao Y, Xu XM, Zhang AM, Qiu XF, Wu JX, Yuan Y, Wang ZN, Qu XJ, Li X, Nie X, Yang M, Cai KL, Zhang WK, Huang Y, Sun Z, Hou ZG, Ma C, Cheng FZ, Tao KX, Zhang T.
    Ann Oncol; 2024 Oct 10; 35(10):882-891. PubMed ID: 38964714
    [Abstract] [Full Text] [Related]

  • 46. Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer.
    Gao YH, Zhang X, An X, Cai MY, Zeng ZF, Chen G, Kong LH, Lin JZ, Wan DS, Pan ZZ, Ding PR.
    Strahlenther Onkol; 2014 Feb 10; 190(2):158-64. PubMed ID: 24408055
    [Abstract] [Full Text] [Related]

  • 47. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
    Swellengrebel HA, Bosch SL, Cats A, Vincent AD, Dewit LG, Verwaal VJ, Nagtegaal ID, Marijnen CA.
    Radiother Oncol; 2014 Jul 10; 112(1):44-51. PubMed ID: 25018000
    [Abstract] [Full Text] [Related]

  • 48. Node-sparing modified short-course Radiotherapy Combined with CAPOX and Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an open-label, single-arm, prospective, multicentre clinical trial.
    Cai C, Zhang X, Sun X, Wang H, Chen E, Chen L, Gu B, Wang J, Huang X, Lao W, Wang X, Chen M, Ding S, Du J, Song Z.
    BMC Cancer; 2024 Oct 09; 24(1):1247. PubMed ID: 39385104
    [Abstract] [Full Text] [Related]

  • 49. Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer.
    Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T, Matsuda C, Mizushima T, Yamamoto H, Doki Y, Mori M, Clinical Study Group of Osaka University (CSGO) Colorectal Group.
    Cancer Chemother Pharmacol; 2018 Oct 09; 82(4):707-716. PubMed ID: 30078098
    [Abstract] [Full Text] [Related]

  • 50. Total Neoadjuvant Therapy (TNT) with Full Dose Concurrent Chemotherapy in Locally Advanced Rectal Adenocarcinoma Including Signet Ring and Mucinous Cancers.
    John AO, Singh A, Bala D, Joel A, Georgy JT, Jesudasan MR, Mittal R, Ram TS, Reddy JR, Murthy A, Chandramohan A, Eapen A, Masih D, Ramnath N, Dobrosotskaya I, Yadav B, Chacko RT.
    J Gastrointest Cancer; 2024 Mar 09; 55(1):307-317. PubMed ID: 37479897
    [Abstract] [Full Text] [Related]

  • 51. Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.
    Zhu J, Liu F, Gu W, Lian P, Sheng W, Xu J, Cai G, Shi D, Cai S, Zhang Z.
    Radiat Oncol; 2014 Mar 07; 9():70. PubMed ID: 24606870
    [Abstract] [Full Text] [Related]

  • 52. Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival.
    Zhang H, Li G, Cao K, Zhai Z, Wei G, Qu H, Wang Z, Han J.
    Int J Colorectal Dis; 2022 Jul 07; 37(7):1657-1668. PubMed ID: 35716183
    [Abstract] [Full Text] [Related]

  • 53. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
    Li SJ, Wang L, Zhang XY, Li YH, Li ZW, Wu Q, Sun YS, Wu AW.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul 25; 22(7):648-655. PubMed ID: 31302963
    [Abstract] [Full Text] [Related]

  • 54. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
    Wang L, Li S, Zhang X, Sun T, Du C, Chen N, Peng Y, Yao Y, Zhan T, Zhao J, Cai Y, Li Y, Wang W, Li Z, Sun Y, Ji J, Wu A.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov 25; 21(11):1240-1248. PubMed ID: 30506534
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [The safety and efficacy of radical surgery after modified total neoadjuvant therapy for locally advanced rectal cancer].
    Zhang L, Yu L, Wu YL, Zhang QQ, Shen SH, Li DD, Fang H, Yang L, Zhang HZ.
    Zhonghua Zhong Liu Za Zhi; 2020 Jun 23; 42(6):501-506. PubMed ID: 32575948
    [Abstract] [Full Text] [Related]

  • 57. 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
    Mitrea D, Barbet N, Pacé-Loscos T, Scouarnec C, Ben-Dhia S, Baron D, Mineur L, Évesque L, Durand-Labrunie J, Gérard JP, Baudin G, Doyen J.
    Cancer Radiother; 2024 Aug 23; 28(4):323-332. PubMed ID: 39003168
    [Abstract] [Full Text] [Related]

  • 58. Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study.
    Czito BG, Deming DA, Jameson GS, Mulcahy MF, Vaghefi H, Dudley MW, Holen KD, DeLuca A, Mittapalli RK, Munasinghe W, He L, Zalcberg JR, Ngan SY, Komarnitsky P, Michael M.
    Lancet Gastroenterol Hepatol; 2017 Jun 23; 2(6):418-426. PubMed ID: 28497757
    [Abstract] [Full Text] [Related]

  • 59. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
    Yang Y, Liu Q, Jia B, Du X, Dai G, Liu H, Chen J, Zeng M, Wen K, Zhu Y, Wang Y, Feng L.
    Technol Cancer Res Treat; 2019 Jan 01; 18():1533033818824367. PubMed ID: 30803368
    [Abstract] [Full Text] [Related]

  • 60. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial.
    Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, Tait D, Massey A, Tebbutt NC, Chau I.
    Lancet Oncol; 2010 Mar 01; 11(3):241-8. PubMed ID: 20106720
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 182.